Evidence map›Paper›PMID 12167702›Full record

ArticleMolecular and cellular biology2002

Inactivation of NF-kappaB-dependent cell survival, a novel mechanism for the proapoptotic function of c-Abl.

Hidehiko Kawai, Linghu Nie, Zhi-Min Yuan

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Post-translational Modifications of IκBα: The State of the Art.Frontiers in cell and developmental biology · 2020
    Review
  7. Article
  8. Global Regulation of Differential Gene Expression by c-Abl/Arg Oncogenic Kinases.Medical science monitor : international medical journal of experimental and clinical research · 2017
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. PTPN13/PTPL1: an important regulator of tumor aggressiveness.Anti-cancer agents in medicinal chemistry · 2011
    Review
  15. Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function.Proceedings of the National Academy of Sciences of the United States of America · 2010
    Article
  16. Article
  17. NF-kappaB activity is constitutively elevated in c-Abl null fibroblasts.Proceedings of the National Academy of Sciences of the United States of America · 2009
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Hidehiko KawaiDepartment of Cancer Cell Biology, Harvard School of Public Health, Boston, Massachusetts 02115, USA.
Linghu Nie
Zhi-Min Yuan
Harvard University · US

Funding

ROLE FOR C ABL KINASE IN DNA DAMAGE INDUCED RESPONSESR29CA076275 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI YUAN, ZHI-MIN · 1998 to 2002
$350k
NCI NIH HHS CA76275-01A1
6 · The paper itself

Abstract

Using a system that expresses a constitutively kinase-active c-Abl protein [c-Abl(KA)], we identified the protein IkappaBalpha as a novel substrate of c-Abl. This kinase-substrate relationship is not only confirmed at the level of endogenous proteins but is also supported by a physical interaction between the two proteins. Interestingly, the association of c-Abl with IkappaBalpha, which is detectable in the form of nonphosphorylated proteins, is remarkably enhanced by an inducible binding of tyrosine-phosphorylated IkappaBalpha to the c-Abl SH2 domain. In contrast to the serine 32/34 phosphorylation that triggers ubiquitination and degradation of IkappaBalpha, c-Abl-mediated phosphorylation at tyrosine 305 is associated with an increase of the IkappaBalpha protein stability. Significantly, this activity is not shared by the oncogenic Bcr-Abl, because it is unique to the nuclear c-Abl. We also demonstrate that c-Abl targets the nuclear subpopulation of IkappaBalpha for phosphorylation and induces it to accumulate in the nucleus. As a consequence, NF-kappaB transcription activity is abolished, leading to an increased cellular sensitivity to the induction of apoptosis. The functional importance of c-Abl-mediated IkappaBalpha phosphorylation is highlighted by a loss of response of the IkappaBalpha(Y305F) protein to c-Abl-mediated regulation. Using cells expressing the c-Abl(KA) protein under the control of an inducible promoter, we demonstrate inactivation of the NF-kappaB-dependent cell survival pathway as one of the mechanisms for c-Abl-mediated apoptosis.

Indexed as

I-kappa B ProteinsProtein Processing, Post-TranslationalAnimalsApoptosisCell LineCell NucleusDNA-Binding ProteinsDoxorubicinFibroblastsFusion Proteins, bcr-ablGenes, ablHumansKidneyMiceMice, KnockoutNF-kappa BDNA-Binding ProteinsDoxorubicinFusion Proteins, bcr-ablI-kappa B ProteinsNF-kappa BNF-KappaB Inhibitor alphaNFKBIA protein, humanNfkbia protein, mousePhosphoserinePhosphotyrosineProto-Oncogene Proteins c-ablRecombinant Fusion Proteins

Identifiers

PMID12167702
PMCPMC134000
OpenAlexW2124760141

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.